![Robert John](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 54 662 $ al 31/05/2026
Robert John is currently Chief Revenue Officer at CVRx, Inc. since 2024.
Formerly, Mr. John was General Manager-Cardiac Rhythm Management EMEA at Abbott Laboratories from 2008 to 2023.
Education includes graduate studies at The University of Alabama and undergraduate studies at the University of North Texas.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CVRX, INC. 0,04 % | 06/04/2026 | 9.796 ( 0,04 % ) | 54 662 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CVRX, INC. | Corporate Officer/Principal | 27/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
 CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
